BIND Biosciences names new president and CEO
This article was originally published in Scrip
Executive Summary
The US biopharmaceutical company BIND Biosciences has named Scott Minick president and chief executive officer. He was formerly a managing director at ARCH Venture Partners, a major BIND investor, and previously president and chief operating officer at Sequus Pharmaceuticals/Liposome Technology.